Venovo Venous Stent System

Stent, Iliac Vein

FDA Premarket Approval P180037

Pre-market Approval Supplement Details

Approval for the venovo venous stent system. The device is indicated for the treatment of symptomatic iliofemoral venous outflow obstruction.

DeviceVenovo Venous Stent System
Classification NameStent, Iliac Vein
Generic NameStent, Iliac Vein
ApplicantBard Peripheral Vascular, Inc.
Date Received2018-09-14
Decision Date2019-03-13
PMAP180037
SupplementS
Product CodeQAN
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address Bard Peripheral Vascular, Inc. 1625 West Third Street tempe, AZ 85281
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P180037Original Filing
S012 2023-01-06 30-day Notice
S011 2022-05-19 30-day Notice
S010 2022-04-26 30-day Notice
S009 2022-03-25 30-day Notice
S008 2021-10-15 Real-time Process
S007 2021-08-09 Normal 180 Day Track No User Fee
S006 2021-07-09 30-day Notice
S005 2021-05-04 30-day Notice
S004 2020-09-02 30-day Notice
S003 2020-08-31 30-day Notice
S002 2020-08-03 30-day Notice
S001 2020-08-03 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.